Spiro-lactam compounds, process and uses thereof
AssigneesUniversidade De Coimbra, Egas Moniz—Cooperativa De Ensino Superior, Crl, Instituto De Medicina Molecular
InventorsTeresa Margarida VASCONCELOS DIAS DE PINHO E MELO, Bruna C. SUZANO SANTOS, Inês BÁRTOLO, Rui Miguel PRUDÊNCIO PIGNATELLI, Nuno Eduardo MOURA DOS SANTOS DA COSTA TAVEIRA
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to a new class of antimicrobial agents. In particular, this disclosure provides the identification and characterization of novel spiro-lactam compounds as anti-HIV/AIDS and anti-malarial agents. Furthermore, this disclosure also provides the preparation of spiro-β-penicillanic acids, which proved to be potent inhibitors of HIV.
Claims11
1-31. (canceled)
A method of treating a patient infected with one or more infectious diseases, the method comprising:
- administering a composition to the patient, wherein the composition comprises
- a therapeutically effective amount of one of the following compounds:
Dependencies are inferred from the claim text.